On 10 June 2022 the President of the Agency for Health Technology Assessment and Tariff System issued the following recommendation:
Recommendation No. 40/2022 of 10 June 2022 of the President of the Agency for Health Technology Assessment and Tariff System on the legitimacy of qualifying the health care service: intravitreal injection – as a guaranteed outpatient specialised care service
Publication in Public Information Bulletin (BIP)